Home›Search›Journal of Neuroimmune Pharmacology

Journal of Neuroimmune Pharmacology

Springer · United States · Est. 2006

ISSN1557-1890eISSN1557-1904

SJR Q1✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (3 more)+18

Total96

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

1.458

H-Indexi

106

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.991

Total Worksi

1,276

Total Citationsi

52,117

2yr Mean Citednessi

4.90

Open Impact Factor alternative

Aims & Scope

Journal of Neuroimmune Pharmacology focuses on the intersection of immunology, pharmacology, and experimental neuroscience. Publishes original interdisciplinary research and broad reviews. Focuses on the pathogenesis and pharmacology of nervous system disorders affecting the immune system. Covers diverse areas including neurodegenerative disorders, psychopharmacology, neurovirology, neuroimmunology, and neuropharmacology. Encourages submissions related to the immunology and pharmacology of human neurologic and neuropsychiatric disorders. Aims to identify novel pharmacologic discoveries of brain-immune interactions with potential to modify disease responses and ameliorate brain injury and immune dysfunction.

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published2006

FrequencyQuarterly

StatusActive (last: 2026)

Total Publications1,276

Publisher OrgSpringer Science+Business Media

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Springer

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1557-1890 / 1557-1904

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

3.1k

2019

2.4k

2020

1.8k

2021

252

2022

597

2023

680

2024

106

435

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

ImmunologyQ1

Immunology and AllergyQ1

Neuroscience (miscellaneous)Q1

PharmacologyQ1

Subject Classification

Web of Science Categories

NeurosciencesPharmacology & Pharmacy

Scopus Categories

PharmacologyNeuroscience (miscellaneous)ImmunologyImmunology and Allergy

Research Topics (OpenAlex)

Neuroinflammation and Neurodegeneration MechanismsHIV Research and TreatmentTryptophan and brain disordersAlzheimer's disease research and treatmentsCannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology ResearchImmune Cell Function and InteractionMultiple Sclerosis Research StudiesNeuropeptides and Animal PhysiologyHIV-related health complications and treatments

Frequently asked questions about Journal of Neuroimmune Pharmacology

Is Journal of Neuroimmune Pharmacology a predatory journal?

PubScope has no integrity flags on record for Journal of Neuroimmune Pharmacology: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Journal of Neuroimmune Pharmacology?

Journal of Neuroimmune Pharmacology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 4.90.

Is Journal of Neuroimmune Pharmacology indexed in Scopus and Web of Science?

Journal of Neuroimmune Pharmacology is indexed in Web of Science, Scopus.